CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
Mar. 31, 2021	Mar. 31, 2020
OPERATING ACTIVITIES:
Net (loss) income	$ 130	$ 3,490
Adjustments to reconcile net income to net cash provided by (used for) operating activities:
Depreciation	7,068	6,650
Amortization, including accretion and write-off of deferred financing costs	1,513	1,429
Deferred income taxes	(1,609)	76
Earnings of equity method investee	(614)	(418)
Loss (gain) on sale of fixed assets	(37)	131
Share-based compensation expense	1,162	1,372
Excess tax benefit related to share-based compensation expense	(319)	17
Gain on disposal of business, net	(739)
Change in fair value of earn-out contingent consideration	72	(633)
Changes in operating assets and liabilities:
Accounts receivable, net	(15,953)	(3,730)
Inventories, net	(7,282)	(5,838)
Prepaid expenses and other assets	(4,744)	(3,702)
Accounts payable	6,725	2,327
Accrued expenses and other liabilities	(2,439)	(7,733)
Net cash provided by operating activities	(17,066)	(6,562)
INVESTING ACTIVITIES:
Capital expenditures, including intangibles	(7,718)	(7,140)
Proceeds from sale of fixed assets	155	8
Proceeds from disposal of business, net	1,050
Investment in venture capital fund	(399)
Net cash used for investing activities	(6,912)	(7,132)
FINANCING ACTIVITIES:
Revolving credit facility borrowings	20,500	71,500
Revolving credit facility payments	(3,000)	(36,500)
Proceeds from issuance of debt	11,434	1,958
Repayments of debt	(13,763)	(2,077)
Common Share repurchase program		(4,995)
Repurchase of Common Shares to satisfy employee tax withholding	(2,347)	(1,687)
Net cash provided by (used for) financing activities	12,824	28,199
Effect of exchange rate changes on cash and cash equivalents	(2,257)	(2,603)
Net change in cash and cash equivalents	(13,411)	11,902
Cash and cash equivalents at beginning of period	73,919	69,403
Cash and cash equivalents at end of period	60,508	81,305
Supplemental disclosure of cash flow information:
Cash paid for interest	1,652	1,150
Cash paid for income taxes, net	$ 3,742	$ 1,832

The aggregate expense charged against earnings to allocate the cost of intangible assets including deferred financing costs (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. Also included in this amount is the accretion of the debt discount and the deferred financing costs which are a component of interest expense representing the periodic charge against earnings to reflect amortization of debt discounts and deferred financing costs over the life of the related debt instrument. As a noncash expense, this element is added back to net income when calculating cash provided by (used in) operations using the indirect method.

No definition available.